Maze Therapeutics, Inc. (MAZE)
46.90
-0.14
(-0.30%)
USD |
NASDAQ |
Feb 13, 15:41
Maze Therapeutics Free Cash Flow : -108.03M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -15.13M |
| LENZ Therapeutics, Inc. | -46.16M |
| Liminatus Pharma, Inc. | -10.38M |
| Oruka Therapeutics, Inc. | -84.60M |
| MapLight Therapeutics, Inc. | -109.22M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.64M |
| Cash from Investing (Quarterly) | -66.88M |
| Cash from Financing (Quarterly) | 143.76M |
| Free Cash Flow Per Share (Quarterly) | -0.514 |
| Free Cash Flow to Equity (Quarterly) | -23.88M |
| Free Cash Flow to Firm (Quarterly) | -24.71M |
| Free Cash Flow Yield | -5.13% |